Prognostic Value of Hyperglycemia on Admission on In-hospital Outcomes in Patients Presenting with ST-elevation Myocardial Infarction.
acute st-elevation myocardial infarction
hyperglycemia
in-hospital mortality
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
17 Feb 2020
17 Feb 2020
Historique:
entrez:
27
3
2020
pubmed:
27
3
2020
medline:
27
3
2020
Statut:
epublish
Résumé
Background Type 2 diabetes mellitus (T2DM) is associated with acute coronary syndrome, and elevated blood glucose levels on hospital admission may influence outcomes in patients with ST-elevated myocardial infarction (STEMI). We conducted this study to determine the prognostic outcome of hyperglycemia at admission on in-hospital outcomes of STEMI patients with and without T2DM. Methods This prospective study was conducted from June 13, 2018, to October 12, 2019, and included patients older than 18 years diagnosed with STEMI. For our purposes, hyperglycemia was defined as blood glucose levels >140 mg/dl. Hypertension was considered as systolic blood pressure >140 mmHg or diastolic pressure > 90 mmHg. The predictive value of glycemia on admission for outcomes was assessed via patient mortality following thrombolysis or percutaneous coronary intervention (PCI). Results Our study included 256 patients (196 men, 76.5%; 60 women, 23.5%) with a mean age of 55 ± 11 years. A total of 92 patients (35.9%) were admitted with known T2DM diagnoses: 72 of them had hyperglycemia and 20 patients had euglycemia (p = 0.0001). Post-PCI mortality was six (18.8%) in the hyperglycemic group and one (2.2%) in the euglycemic group (p = 0.03). In-hospital mortality was higher in the hyperglycemic group (n = 12, 12.5%) compared to the euglycemic group (n = 6, 3.7%; p = 0.015). Significant risk factors of mortality for STEMI patients with hyperglycemia on admission were age 60 years or older (odds ratio [OR], 5.63 [1.54-20.58]; p = 0.007), heart failure on admission (OR, 6.84 [1.85-25.22)]; p = 0.003), T2DM (OR, 4.14 [0.50-33.96]; p = 0.05), and presenting with renal failure (OR, 6.78 [1.74-26.42]; p = 0.009). Conclusion Thrombolysis and PCI are effective and safe treatments in STEMI patients. Hyperglycemia has a great adverse impact on hospital outcomes in patients with or without T2DM. STEMI patients with hyperglycemia on hospital admission have higher mortality rates.
Identifiants
pubmed: 32211260
doi: 10.7759/cureus.7024
pmc: PMC7081956
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e7024Informations de copyright
Copyright © 2020, Shahid et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Circulation. 2011 Aug 9;124(6):704-11
pubmed: 21768543
BMJ Open. 2019 Feb 21;9(2):e025300
pubmed: 30796126
Cardiovasc Diabetol. 2017 Jul 11;16(1):89
pubmed: 28697774
N Engl J Med. 2015 Nov 26;373(22):2117-28
pubmed: 26378978
Zhonghua Liu Xing Bing Xue Za Zhi. 2008 Jun;29(6):526-9
pubmed: 19040029
Indian Heart J. 2018 Nov - Dec;70(6):772-776
pubmed: 30580843
Circulation. 1999 May 25;99(20):2626-32
pubmed: 10338454
Am J Cardiol. 2006 Oct 15;98(8):1000-3
pubmed: 17027559
Eur Heart J. 2013 Oct;34(39):3035-87
pubmed: 23996285
Am J Cardiol. 2014 Dec 15;114(12):1789-93
pubmed: 25438903
Int J Cardiol. 2013 Sep 10;167(6):2572-9
pubmed: 22795245
Cardiovasc Diabetol. 2017 Jan 6;16(1):1
pubmed: 28057001
Diabetes Care. 2003 Jul;26(7):2181-8
pubmed: 12832332
Int J Cardiol. 2017 Jun 1;236:9-15
pubmed: 28126258
Cardiovasc Diabetol. 2018 Jan 24;17(1):20
pubmed: 29368615
J Thromb Haemost. 2004 Aug;2(8):1282-91
pubmed: 15304032